Ionis to present at upcoming investor conferences

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) announced participation in two upcoming investor conferences:

• 3rd Annual Stifel CNS Day on April 1, 2021
• 20th Annual Needham Healthcare Conference on April 12, 2021

Updates on presentation details will be available on the company's website. A live webcast will be accessible in the Investors & Media section, with replays available within 48 hours. Ionis, a pioneer in RNA-targeted therapies, boasts three marketed medicines and a robust pipeline, especially in neurological and cardiometabolic fields.

CARLSBAD, Calif., March 26, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced that management will participate in virtual fireside chats at the following investor conferences:

• 3^rd Annual Stifel CNS Day on Thursday, April 1, 2021
• 20^th Annual Needham Healthcare Conference on Monday, April 12, 2021

The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.ionispharma.com for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma.

View original content to download multimedia:http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301256446.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When is Ionis Pharmaceuticals participating in investor conferences?

Ionis Pharmaceuticals will participate in the 3rd Annual Stifel CNS Day on April 1, 2021, and the 20th Annual Needham Healthcare Conference on April 12, 2021.

Where can I find live updates for Ionis Pharmaceuticals' conference presentations?

Live updates and presentation details can be found on Ionis Pharmaceuticals' website.

Will there be a webcast of Ionis Pharmaceuticals' conference presentations?

Yes, a live webcast of the presentations will be available on the Investors & Media section of the Ionis website.

How can I access the replays of Ionis Pharmaceuticals' conference presentations?

Replays of the presentations will be available within 48 hours after the live event and will be archived for a limited time.

What is the focus of Ionis Pharmaceuticals' research and development?

Ionis Pharmaceuticals focuses on RNA-targeted therapeutics, with strengths in neurological and cardiometabolic areas.